ArticleScientific reports2025
Correlation of broad-spectrum antibiotic utilization patterns with invasive candidiasis in critically ill patients and development of an early prediction model.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Cumulative respiratory pathogen detection burden by multiplex PCR is associated with mortality in a TB-enriched ICU cohort.Microbiology spectrum · 2026Article
- Clinical Predictors of Nose/Throat Bacteriome and Fungal Colonization in Skilled Nursing Facility Residents.The Journal of infectious diseases · 2026Article
- Immunosuppression is associated with loss of airway microbiome resilience in severe COVID-19.Microbiome · 2026Article
- Analysis of Antibiotic Consumption Trends and Pathogens' Epidemiological Profile Within a Multidisciplinary Clinical Hospital from Romania.Antibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Invasive candidiasis (IC) remains an infection with high incidence and mortality rates in the ICU setting, particularly among patients treated with broad-spectrum antibiotics. This study aims to investigate the association between detailed antibiotic usage profiles and the occurrence of IC, and to develop an IC-predictive model specialized for patients who received broad-spectrum antibiotics. We retrospectively collected detailed information on antibiotic categories, treatment duration, combination therapies and other clinical data of enrolled patients. Univariate and multivariate logistic regression analyses were performed to identify risk factors for IC and to construct a nomogram model. We analyzed 1,260 patients treated with broad-spectrum antibiotics and 877 without. After adjusting for IC-related risk factors using propensity score matching (PSM) and inverse probability of treatment weighting (IPTW), broad-spectrum antibiotics remained an independent risk factor for IC. Among patients receiving antibiotic monotherapy, lipopeptides, glycopeptides and oxazolidinones were the top three antibiotic classes associated with an increased risk of IC. The duration of antibiotic therapy showed a positive correlation with IC risk. Combination therapy significantly increased the risk of IC (odds ratio [OR] = 2.341, 95% confidence interval [CI]: 1.316-4.162), with the combination of beta-lactams/beta-lactamase inhibitors and glycopeptides showing the highest IC risk. Based on univariate and multivariate regression analyses, we developed an IC risk nomogram specific to patients receiving broad-spectrum antibiotics, including smoking history, sepsis, continuous renal replacement therapy (CRRT), prognostic nutritional index (PNI), use of beta-lactams/beta-lactamase inhibitors and plasma (1,3)-β-D-glucan (BDG) positivity. The model demonstrated good predictive performance with an area under the curve (AUC) of 0.863 (95% CI: 0.806-0.920) in the training dataset and 0.784 (95% CI: 0.685-0.883) in the validation dataset. Decision curve analysis (DCA) and clinical impact curve (CIC) analysis demonstrated favorable clinical benefits of the model. Our findings suggest that specific antibiotic profiles-type, duration, and combination-were significantly associated with IC. Furthermore, we developed a nomogram to predict IC risk among patients treated with broad-spectrum antibiotics, which showed good predictive performance and potential clinical utility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.